Eisai
4523.T
#2297
Rank
HK$64.25 B
Marketcap
HK$227.67
Share price
-0.60%
Change (1 day)
-3.29%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): HK$6.78

According to Eisai's latest financial reports the company's current EPS (TTM) is HK$6.80. In 2026 the company made an earnings per share (EPS) of HK$6.77 a decrease over its 2025 EPS that were of HK$8.57.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026HK$6.77-21.04%
2025HK$8.5711.85%
2024HK$7.66-32.63%
2023HK$11.385.52%
2022HK$10.78-74.01%
2021HK$41.48-66.58%
2020HK$124.0998.24%
2019HK$62.5917.01%
2018HK$53.4937.78%
2017HK$38.83-27.62%
2016HK$53.6435.33%
2015HK$39.64-2.82%
2014HK$40.79-27.66%
2013HK$56.39-27.49%
2012HK$77.77-12.67%
2011HK$89.0688.08%
2010HK$47.35-11.06%
2009HK$53.24-390.15%
2008-HK$18.35-127.78%
2007HK$66.06347.11%
2006HK$14.784.38%
2005HK$14.167.4%
2004HK$13.1843.03%
2003HK$9.2225.09%
2002HK$7.3752.67%
2001HK$4.8369.76%
2000HK$2.84